Legislators
Bills
Statements
Lobbying
Travel
- Bills
- S.3565
S.3565: Opioid Advocacy Transparency Act of 2018
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced Oct. 10, 2018
- Latest Major Action Oct. 10, 2018
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in Senate - Oct. 10, 2018
Bill Summary
Opioid Advocacy Transparency Act of 2018 This bill expands reporting requirements related to the ownership and investment interests of certain patient-advocacy organizations. Under current law, a manufacturer of drugs, devices, or medical supplies that are covered under Medicaid or Medicare must regularly report on any payment or transfer of value by the manufacturer to a "covered recipient," defined as either a physician who is not an...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Oct. 10, 2018 |
Read twice and referred to the Committee on Finance.
|
Oct. 10, 2018 |
Introduced in the Senate by Claire McCaskill (D-Mo.) |